5 ms·
Someone needs to make an anthology of first-person stories about trying out Theranos. I actually thought the OP article was by John Carreyrou because I saw it i
by danso 9y ago
Someone needs to make an anthology of first-person stories about trying out Theranos. I actually thought the OP article was by John Carreyrou because I saw it in his tweets (and it makes sense that they'd pull the fire alarm upon seeing him), but it's by a reporter (Jenny Gold) from Kaiser Health News, who apparently visited there (Nov 2014) before Carreyrou's WSJ investigation was published in October 2015.
The only other stories I can think of are:
Eric Lakin (DeciBio Consulting), 10/2015: https://www.washingtonpost.com/news/wonk/wp/2015/10/27/what-happened-when-i-tried-the-new-blood-test-that-was-supposed-to-change-the-world/ https://www.washingtonpost.com/news/wonk/wp/2015/10/27/what-...
Jean-Louis Gassee (former Apple exec), 10/2015: https://mondaynote.com/theranos-trouble-a-first-person-account-1690b827539f https://mondaynote.com/theranos-trouble-a-first-person-accou...
Melia Robinson (Business Insider), 10/2015:
http://www.businessinsider.com/i-tried-theranos-2015-10 http://www.businessinsider.com/i-tried-theranos-2015-10
- deleted 9y ago[deleted]
- wpietri 9y agoI would also love to see a survey of the journalism on this. We see now that Theranos's stuff never worked. But tech press is famously uncritical. It seems like there's an opportunity for all of us to learn something here about how we were so easily misled.
- nathanaldensr 9y agoMany people were skeptical, even right here on HN. Sometimes, their voices are drowned out by those that like to accuse the skeptical of being pessimistic. Optimism can be inherently unscientific--it can often be a manifestation of what we want rather than what is scientifically likely. To me, the battle has always been between optimism and realism.
- danso 9y agoThe seems to be the oldest post on HN (Sept 8 2013, 211 upvotes, 113 comments) https://news.ycombinator.com/item?id=6349349 https://news.ycombinator.com/item?id=6349349 It doesn't feel that much more skeptical than typical HN threads about new companies. And skepticism/confusion was going to be more prevalent given how few HN users (relatively speaking) are in the health field. Funny enough, if you scroll down far enough, you run into a comment that sounds like it came from a prophet. Or someone experienced in the field: > The company is all hot air. They have a board full of retired military figure heads that have no experience in medical devices or retail services. Additionally, they do not have any products to show. Look at their patents. They are all very general and broad. There has been NO FDA CLEARANCE for anything they are doing, which raises legal questions. Speaking of legal, search for lawsuits they are involved in. Their core technology is not even theirs. They stole it from someone else. That the board was heavy DC/military was well-known, or at least public. But I don't think it was well known that Theranos was heavily reliant on using other technology. Sadly, that Theranos critique came from a one-use throwaway account. So likely an insider (or jealous competitor)?
- avs733 9y agoI'm not there comment you referene, but for around three or four years I have been using theranos' board as a teaching tool in undergraduate entrepreneurship courses.
- mkesper 9y agoYou mean teaching what not to do, I hope?
- thaumasiotes 9y agoHuh? The board was a major success, the only thing Theranos had going for it.
- blueprint 9y agoTypically we pragmatists consider guiding the company to avoid implosion as a criterion for a successful board.
- danieltillett 9y agoThe reason Theranos was always a fraud is it is well known (as in for decades) that you can’t get reliable sampling from a finger prick sample even with a perfect detector. The reason why is that the blood from a finger prick is a random mixture of veinous and arterial blood with a variable amount of cell debris and contamination from what is on the skin. Not even Kissinger (sorry I mean Lucifer) could give you an accurate diagnosis based on finger prick.
- fwgwgwgch 9y agoNoble peace prize winner ;) (I agree with your sentiment, just pointed out this to remind people that these prizes are not given by God)
- saiya-jin 9y agoThey are not even given by same committee as 'real' nobels, and are used as a political statement at current time, often end up being a huge embarrassment after some time. I mean, Yasser Arafat (+-terrorist), Al Gore (for a environmental powerpoint), Obama (happy continuing supporting Guantanamo and 2 horrible unjust wars), Aung San Suu Kyi (happy with recent Rohinga genocide), Kissinger and so on. There are often candidates for it which would actually deserve it, but since it's a vessel for political statements, they usually don't get it.
- jamesrcole 9y agoI don't think it's primarily about optimism vs realism. Those are attitudes, and I think the matter is more epistemological - about what valid conclusions we can draw based on the known details. For example, if we have incomplete information and we can't draw clear conclusions from it, rather than thinking of what sort of attitude we should take towards it (or optimistic vs cynical) -- what we think is likely the case -- our first step should be to admit the incomplete information and be agnostic about what's actually the truth of the matter. If there are particular reasons for thinking one option (eg fraud) is likely then you can list first reasons and the facts that support them. Doing so doesn't and shouldn't have to involve an attitude like realism or cynicism.
- danso 9y agoTheranos is an interesting case. Benedict Evans tweeted something interesting the other week [0], how Theranos, unlike virtually every other Silicon Valley startups, was very East Coast in style. Particularly with its board full of old, famous politicians and DC figures like Kissinger and General Mattis. I didn't really hear much about it until the WSJ blowup, but my perception was that Theranos wasn't in whatever scene that other startups are in when they get coverage from TechCrunch, etc. I know Tim Draper was an early VC backer (his daughter was childhood friends with Elizabeth Holmes), but did other Silicon VC know much about Theranos? I know Theranos did end up getting TechCrunch-west-coast-style coverage (I mean, before WSJ blew it up). But I'm pretty sure that its very first press splashes were with the Wall Street Journal in Sept. 2013 [1] and then the New Yorker in Dec. 2014 [2]. The WSJ article was very interesting. Not just because it's ironic, given that a WSJ investigative reporter would be taking Theranos down. But because of the setup. It was weekend interview feature assigned to a Pulitzer Prize-winning editorial board member. And, unlike the New Yorker piece, was almost entirely a puff piece. Interestingly enough, though, the author describes the experience of having blood drawn via the fingerstick/nanotainer setup (i.e. the tech Theranos was aiming for). Having your first public splash in the WSJ Weekend Magazine seems like a very East Coast thing. Amusingly, when Theranos was burning down, it was revealed that Rupert Murdoch had a $125 million stake in Theranos [3]. Which probably explains the WSJ puff piece, since Murdoch owns the WSJ. This is all to say that Theranos's early years as a startup seems to have been much different culturally than the usual Bay Area startup. I wonder how Theranos would've fared or been different if it had operated like a highly-funded SV startup (Color, Clinkle, or any other high-funded startup that didn't die out) with the same hype and attention. [0] https://twitter.com/BenedictEvans/status/972501945813381122 https://twitter.com/BenedictEvans/status/972501945813381122 [1] http://archive.is/8dfJ7 http://archive.is/8dfJ7 [2] https://www.newyorker.com/magazine/2014/12/15/blood-simpler https://www.newyorker.com/magazine/2014/12/15/blood-simpler [3] https://www.bizjournals.com/sanjose/news/2017/03/24/rupert-murdoch-theranos-elizabeth-holmes.html https://www.bizjournals.com/sanjose/news/2017/03/24/rupert-m...
- OrganicMSG 9y agoPerhaps they weren't trying to develop anything at all. How many samples did they get before the lid got blew?
- mannykannot 9y agoOne of those techniques is on display here: make it absolutely clear that a journalist will have no access unless they relinquish editorial control and remain unswervingly positive. This is what should have been reported at the time, but wasn't.
- wpietri 9y agoYes. The PR people were so casual about attempting to control the story that I have to think they normally got away with it. In some ways, the "let a thousand flowers bloom" effect that the Internet has on journalism has made this worse. The more options a PR person has for getting stories out, the less power any individual reporter has.
- rdiddly 9y agoI note an interesting stubbornness in all three of your links, where each writer seems determined to carry on with their preordained mission of fellating Theranos in print, even after smelling something fishy. Depressing indictment of journalists and journalism. The NPR reporter at least had the nerve to cancel the feature. Though redoubling her efforts into an even fiercer and more thorough investigation would have been great.